StonvexLoading…
StonvexStonvexStonvexCore line items from MGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $25.21M | $52.30M | $44.76M |
Operating Income | $-96.01M | $-88.90M | $-78.49M |
Net Income | $-87.87M | $-78.06M | $-68.25M |
EPS (Diluted) | $-2.36 | $-2.36 | $-20.05 |
Total Assets | $221.10M | $324.60M | $364.84M |
Total Liabilities | $62.51M | $89.74M | $149.67M |
Cash & Equivalents | $41.72M | $27.39M | $140.60M |
Free Cash Flow OCF − CapEx | $-89.47M | $-112.19M | $-101.22M |
Shares Outstanding | 37.62M | 37.42M | 3.40M |